Kanabo Group Plc (KNB.L) Research

Kanabo Group Plc specializes in the creation and distribution of cannabis-derived offerings tailored for medical patients. The company also provides cannabidiol (CBD) products, specifically those without tetrahydrocannabinol (THC), for general consumers. All its merchandise is marketed under the Kanabo brand. Founded in 2016, this London, United Kingdom-based firm operates as a subsidiary of Altshuler Shaham Trusts Ltd.

Market snapshot

Symbol
KNB.L
Price
$0.23
Day change
-25.00%
Market cap
$1.4M
P/E ratio
-0.15x
52-week range
0.15-2
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • Cel AI PLC (CLAI.L)
  • DeepVerge plc (DVRG.L)
  • Hellenic Dynamics Plc (HELD.L)
  • LungLife AI, Inc. (LLAI.L)
  • LungLife AI, Inc. (LLA.L)
  • Oxford Cannabinoid Technologies Holdings Plc (OCTP.L)
  • Oncimmune Holdings plc (ONC.L)
  • Ovoca Bio plc (OVB.L)

Open Kanabo Group Plc (KNB.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.